Insider · CIK 0001614741

Lefebvre Eric

Reports to the SEC for 3 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001614741

Forms 4 and 5

Insider transactions

41 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-01-23	PLRXPLIANT THERAPEUTICS, INC.A Award	Chief Medical Officer	AAward	+45.7K sh	—	—	240,224
2025-01-23	PLRXPLIANT THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+91.3K sh	—	—	91,300
2025-01-17	PLRXPLIANT THERAPEUTICS, INC.S Sale	Chief Medical Officer	SSale	−18.5K sh	$11.20	−$207K	194,574
2024-07-10	PLRXPLIANT THERAPEUTICS, INC.S Sale	Chief Medical Officer	SSale	−12.3K sh	$11.56	−$142K	213,052
2024-07-09	PLRXPLIANT THERAPEUTICS, INC.A Award	Chief Medical Officer	AAward	+24.1K sh	—	—	225,371
2024-03-22	CymaBay Therapeutics, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−115K sh	—	—	0
2024-03-22	CymaBay Therapeutics, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−25K sh	—	—	0
2024-03-22	CymaBay Therapeutics, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−14K sh	—	—	0
2024-01-24	CymaBay Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+14K sh	—	—	14,010
2024-01-23	PLRXPLIANT THERAPEUTICS, INC.A Award	Chief Medical Officer	AAward	+42.9K sh	—	—	199,820
2024-01-23	PLRXPLIANT THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+85.8K sh	—	—	85,800
2024-01-17	PLRXPLIANT THERAPEUTICS, INC.S Sale	Chief Medical Officer	SSale	−10.3K sh	$17.23	−$177K	156,920
2023-07-17	PLRXPLIANT THERAPEUTICS, INC.S Sale	Chief Medical Officer	SSale	−22.3K sh	$18.01	−$402K	167,215
2023-07-14	PLRXPLIANT THERAPEUTICS, INC.A Award	Chief Medical Officer	AAward	+43.8K sh	—	—	189,536
2023-03-30	PLRXPLIANT THERAPEUTICS, INC.S Sale	Chief Medical Officer	SSale	−11.2K sh	$26.52	−$298K	145,786
2023-03-29	PLRXPLIANT THERAPEUTICS, INC.A Award	Chief Medical Officer	AAward	+21.9K sh	—	—	157,031
2023-01-25	CymaBay Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2023-01-25	PLRXPLIANT THERAPEUTICS, INC.A Award	Chief Medical Officer	AAward	+57K sh	—	—	133,926
2023-01-25	PLRXPLIANT THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+80K sh	—	—	80,000
2023-01-23	PLRXPLIANT THERAPEUTICS, INC.S Sale	Chief Medical Officer	SSale	−67.5K sh	$34.48	−$2.33M	76,926
2022-12-20	PLRXPLIANT THERAPEUTICS, INC.S Sale	Chief Medical Officer	SSale	−10.9K sh	$19.10	−$208K	144,426
2022-12-19	PLRXPLIANT THERAPEUTICS, INC.A Award	Chief Medical Officer	AAward	+21.9K sh	—	—	155,313
2022-10-25	PLRXPLIANT THERAPEUTICS, INC.S Sale	Chief Medical Officer	SSale	−5,000 sh	$25.05	−$125K	133,437
2022-07-11	PLRXPLIANT THERAPEUTICS, INC.S Sale	Chief Medical Officer	SSale	−3,000 sh	$20.00	−$60K	138,436
2022-03-21	CymaBay Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+115K sh	—	—	115,000
2022-01-26	PLRXPLIANT THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+140K sh	—	—	140,000
2021-06-18	PLRXPLIANT THERAPEUTICS, INC.S Sale	Chief Medical Officer	SSale	−8,750 sh	$28.62	−$250K	140,830
2021-06-18	PLRXPLIANT THERAPEUTICS, INC.S Sale	Chief Medical Officer	SSale	−3,728 sh	$29.43	−$110K	137,102
2021-06-18	PLRXPLIANT THERAPEUTICS, INC.S Sale	Chief Medical Officer	SSale	−22 sh	$30.23	−$665.06	137,080
2021-03-18	PLRXPLIANT THERAPEUTICS, INC.S Sale	Chief Medical Officer	SSale	−11.4K sh	$39.38	−$448K	150,715
2021-03-18	PLRXPLIANT THERAPEUTICS, INC.S Sale	Chief Medical Officer	SSale	−1,135 sh	$39.78	−$45.2K	149,580
2021-01-23	PLRXPLIANT THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+73.3K sh	—	—	73,250
2020-12-18	PLRXPLIANT THERAPEUTICS, INC.S Sale	Chief Medical Officer	SSale	−6,788 sh	$26.17	−$178K	167,792
2020-12-18	PLRXPLIANT THERAPEUTICS, INC.S Sale	Chief Medical Officer	SSale	−5,712 sh	$26.98	−$154K	162,080
2016-11-01	Tobira Therapeutics, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−79.3K sh	—	—	0
2016-11-01	Tobira Therapeutics, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−100K sh	—	—	0
2016-11-01	Tobira Therapeutics, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−101K sh	—	—	0
2016-01-12	Tobira Therapeutics, Inc.Stock Options (right to buy)A Award	Chief Medical Officer	AAward	+101K sh	—	—	101,000
2015-05-15	Tobira Therapeutics, Inc.Stock Options (right to buy)A Award	Chief Medical Officer	AAward	+100K sh	—	—	100,000
2015-05-04	Tobira Therapeutics, Inc.Stock Options (right to buy)A Award	Chief Medical Officer	AAward	+79.3K sh	—	—	79,287
2015-05-04	Tobira Therapeutics, Inc.Stock Options (right to buy)A Award	Chief Medical Officer	AAward	+21.6K sh	—	—	100,894

Recent filings

Accepted (ET)
Jan 274
Lefebvre Eric0001746473-25-000013
SEC(opens sec.gov)
Jan 224
Lefebvre Eric0001746473-25-000003
SEC(opens sec.gov)
Jul 124
Lefebvre Eric0001746473-24-000129
SEC(opens sec.gov)
Jul 114
Lefebvre Eric0001746473-24-000119
SEC(opens sec.gov)
Mar 224
Lefebvre Eric0000950170-24-035468
SEC(opens sec.gov)
Jan 264
Lefebvre Eric0001062993-24-001418
SEC(opens sec.gov)
Jan 244
Lefebvre Eric0001746473-24-000017
SEC(opens sec.gov)
Jan 194
Lefebvre Eric0001746473-24-000002
SEC(opens sec.gov)
Jul 194
Lefebvre Eric0001209191-23-042831
SEC(opens sec.gov)
Jul 184
Lefebvre Eric0001209191-23-042660
SEC(opens sec.gov)
Apr 34
Lefebvre Eric0001209191-23-022374
SEC(opens sec.gov)
Mar 314
Lefebvre Eric0001209191-23-021921
SEC(opens sec.gov)
Jan 274
Lefebvre Eric0001140361-23-003178
SEC(opens sec.gov)
Jan 274
Lefebvre Eric0001062993-23-001495
SEC(opens sec.gov)
Jan 254
Lefebvre Eric0001140361-23-002784
SEC(opens sec.gov)

Companies

Address

C/O PLIANT THERAPEUTICS, INC. 331 OYSTER POINT BOULEVARD

SOUTH SAN FRANCISCO, CA, 94080